Searching…
CYP2C19 is a gene that encodes a cytochrome P450 protein that catalyzes the metabolism of many drugs and fatty acids. Learn about its function, polymorphism, pharmacogenomics, and clinical implications for antiplatele...
The CYP2C19 gene is frequently included in different pharmacogenomic panels tested in clinical practice, due to its involvement in the metabolism of a myriad of frequently prescribed medications.
The CYP2C19 enzyme is a protein primarily expressed in the liver, where it performs its function of drug metabolism. Its main role involves chemically modifying drug compounds to prepare them for elimination from the body.
The CYP2C19 gene provides instructions for making an enzyme that is found primarily in liver cells in a cell structure called the endoplasmic reticulum, which is involved in protein processing and transport.
Apr 29, 2025 · CYP2C19 is part of the cytochrome P450 family, a group of liver enzymes responsible for drug metabolism. As a phase I enzyme, it facilitates oxidation, transforming lipophilic substances into more hydro...
Sep 1, 2023 · CYP2C19 is a liver enzyme that oxidizes many medications, affecting their efficacy and side effects. Learn how genetic variations in CYP2C19 can influence drug responses and what medications are metaboli...
CYP2C19 is a gene that encodes a cytochrome P450 enzyme that metabolises many medicines. Learn about its function, variants, genotypes, pharmacogenetic guidelines and how to interpret metaboliser status.
CYP2C19 CYP2C19 is a minor CYP, but it has been well studied. Its substrates include barbiturates, diazepam, phenytoin, amitryptyline, and proton pump inhibitors. Individuals are classified as EM or PM, with a PM freq...
Jan 14, 2026 · CYP2C19 is a gene that encodes a cytochrome P450 enzyme involved in drug metabolism and fatty acid hydroxylation. Learn about its aliases, disorders, pathways, products, variants, and more from GeneCard...
Jun 20, 2024 · Such patients can be identified by CYP2C19 genetic testing and can be treated with alternative therapy. Conversely, universal use of potent oral P2Y12 inhibitors such as ticagrelor or prasugrel, which a...
